Entegris (ENTG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 net sales reached $850 million, up 11% year-over-year excluding divestitures, with record sales in both Material Solutions and Advanced Purity Solutions divisions.
Full-year 2024 adjusted net sales excluding divestitures grew 4.6% to $3,207.3 million, outperforming the market by 3-4 points.
Profitability was strong: Q4 adjusted EBITDA margin was 29.2%, and non-GAAP EPS was $0.84, both above guidance.
Advanced logic and AI-related semiconductor customers drove growth, while mainstream and memory segments remained weak.
Segment realignment now reports two segments: Materials Solutions (MS) and Advanced Purity Solutions (APS).
Financial highlights
Q4 2024 sales reached $850 million, up 11% year-over-year excluding divestitures; as-reported sales up 5%.
Q4 2024 gross margin was 45.6% (GAAP and non-GAAP), up from 42.4% a year ago.
Q4 2024 adjusted EBITDA margin was 29.2%; full-year adjusted EBITDA was $931.1 million, 28.7% of sales.
Q4 2024 non-GAAP EPS was $0.84, above guidance; GAAP EPS was $0.67.
Full-year free cash flow was $316 million, with a margin of nearly 10%.
Outlook and guidance
2025 sales expected at ~$3.4 billion, up ~6.5% pro forma; market growth forecast at 1-3%.
Outperformance of 4-5 points over the market expected, despite $30-$40 million revenue loss from China restrictions.
Q1 2025 sales guidance: $775-$805 million, up ~7% year-over-year at midpoint; gross margin 45.5-46.5%.
Q1 2025 non-GAAP net income guidance: $97M–$108M; non-GAAP EPS: $0.64–$0.71; adjusted EBITDA margin expected at 28.0%-29.0%.
CapEx for 2025 expected at $325 million (~10% of sales); net interest expense ~$200 million.
Latest events from Entegris
- Q1 2025 net sales were $773.2M, with Q2 guidance reflecting tariff-driven uncertainty.ENTG
Q1 20258 Jul 2026 - Q1 2026 delivered 5% sales growth, margin expansion, and strong cash flow for deleveraging.ENTG
Q1 20261 May 2026 - Abstentions and broker non-votes now count against eliminating supermajority requirements.ENTG
Proxy filing26 Mar 2026 - Annual meeting to vote on directors, compensation, auditor, and key shareholder rights changes.ENTG
Proxy filing23 Mar 2026 - Proxy covers leadership transition, governance reforms, and performance-based compensation changes.ENTG
Proxy filing23 Mar 2026 - Strategic growth, governance reforms, and enhanced ESG drive long-term value creation.ENTG
Proxy Filing6 Mar 2026 - Q4 2025 delivered strong sales and margins, with robust 2026 guidance and ongoing deleveraging.ENTG
Q4 202510 Feb 2026 - Q2 sales rose sequentially with strong margins; Q3 guidance and investments support further growth.ENTG
Q2 20242 Feb 2026 - Adjusted sales up 7% year-over-year; Q4 outlook signals margin strength and cost savings.ENTG
Q3 202417 Jan 2026